Influence of Submacular Hemorrhage at Baseline on the Long-Term Outcomes of Aflibercept Treatment for Typical Neovascular AMD and PCV
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Graefe's Archive for Clinical and Experimental Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
Graefes Arch. Clin. Exp. Ophthalmol 2024 Oct 01;262(10)3099-3107, MM Hosokawa, C Ouchi, Y Shiode, S Kimura, R Matoba, T Morita, Y MorizaneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.